Review of the Management of Relapsed/Refractory Follicular Lymphoma: An Italian Perspective
Sign Up to like & getrecommendations! Published in 2025 at "Hematological Oncology"
DOI: 10.1002/hon.70140
Abstract: Follicular lymphoma (FL) is an indolent disease characterized by multiple relapses and eventual refractoriness to therapy. Despite advancements in therapeutic approaches, FL treatment algorithm and management remain not well‐established, necessitating both ongoing research into novel… read more here.
Keywords: relapsed refractory; management relapsed; review management; follicular lymphoma ... See more keywords
Management of relapsed cutaneous T‐Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient case
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15538
Abstract: Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is a potentially curative treatment option for patients with refractory cutaneous T‐cell lymphoma (CTCL) through replacement of the bone marrow responsible for lymphoma cells and possibly induction of a… read more here.
Keywords: cell; management relapsed; lymphoma; review ... See more keywords
The Management of Relapsed and Refractory Multiple Myeloma.
Sign Up to like & getrecommendations! Published in 2023 at "Oncology"
DOI: 10.46883/2023.25920991
Abstract: The treatment of patients with relapsed and refractory multiple myeloma has become increasingly complex due to the rising number of available therapies. Patients are also increasingly exposed to, and refractory to, multiple classes of therapy… read more here.
Keywords: management relapsed; relapsed refractory; myeloma; refractory multiple ... See more keywords